Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook
Research ArticleOriginal Article

Autophagic flux response and glioblastoma sensitivity to radiation

Achilleas G. Mitrakas, Dimitra Kalamida, Alexandra Giatromanolaki, Stamatia Pouliliou, Avgi Tsolou, Rafail Kyranas and Michael I. Koukourakis
Cancer Biology & Medicine August 2018, 15 (3) 260-276; DOI: https://doi.org/10.20892/j.issn.2095-3941.2017.0173
Achilleas G. Mitrakas
1Department of Radiotherapy/Oncology
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dimitra Kalamida
1Department of Radiotherapy/Oncology
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alexandra Giatromanolaki
2Department of Pathology, Democritus University of Thrace, and University General Hospital of Alexandroupolis, Alexandroupolis 68100, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stamatia Pouliliou
1Department of Radiotherapy/Oncology
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Avgi Tsolou
1Department of Radiotherapy/Oncology
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rafail Kyranas
1Department of Radiotherapy/Oncology
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael I. Koukourakis
1Department of Radiotherapy/Oncology
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: [email protected]
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • 1
    • Download figure
    • Open in new tab
    • Download powerpoint
    1

    (A) Western blot images of the response of T98 and U87 cell lines, 2 and 7 days after 4Gy irradiation, examined in the pellet fraction (where the autophagosomes reside) for LC3A (16 KDa), LC3B (16 KDa), p62 (60 KDa), LAMP2a (100 KDa) and CTSD (34 KDa), and in the nuclear fraction for TFEB (55 KDa). (B) Band densitometry of the Western blots (performed in triplicates). The Y-axis shows the fold increase compared to time point 0 h (*P < 0.05, ** P < 0.01, *** P < 0.001). (C) Typical images (100 x) of aggresome (red) accumulation following exposure of cells to the proteasome inhibitor MG132 (positive control) and 4 Gy irradiation. (D) Confocal microscopy images (100 x) of LC3A (green)/LAMP2a (red), LC3B (red)/CTSD (green) colocalization and of p62 (red) protein expression, following 4 Gy irradiation.

  • S1
    • Download figure
    • Open in new tab
    • Download powerpoint
    S1

    Western blot images of the LC3A and LC3B proteins, in the pellet fraction of the T98 and U87 glioblastoma cells, 48 h and 7days after exposure to 4Gy of radiation.

  • S2
    • Download figure
    • Open in new tab
    • Download powerpoint
    S2

    In order to confirm that LC3A-LAMP2Aor LC3B-CTSD imaging indeed records “autophagic flux” changes, T98 and U87 cells were incubated with Bafilomycin A, (100 nM) for 24h. The autophagosome and lysosome fusion was disrupted as it is demonstrated in the relevant confocal microscopy images. As the drug has its major effect on slowing the degradation of LC3-II within existing autolysosomes, incubation for 24h results to accumulation of LC3A or LC3B auto-lysosomes. This, however, was more prominent in the T98 cell line.

  • 2
    • Download figure
    • Open in new tab
    • Download powerpoint
    2

    (A) Relative quantitative analysis of mRNA levels of the LC3A, LC3B, p62, TFEB, LAMP2a and CTSD mRNA levels at 0, 2 and 7 days after exposure of T98 and U87 cells lines to 4 Gy of radiation (*P < 0.05, **P < 0.01, ***P < 0.001). (B) γH2AX nuclear foci expression and image densitometry of nuclear staining of T98 and U87 cell lines exposed to escalated doses of radiation. (C) Detection of apoptosis in T98 and U87 cell lines, assessed with confocal microscopy, following 4 Gy of irradiation, at various time points (typical confocal images, fluorescence intensity assessment and % of apoptotic cells) (40 x). (D) Caspase 9 (csp9) expression levels in the T98 and U87 cell lines, at 2 and 7 days, following exposure to 4 Gy radiation. (E) Percent of cells with SA-β-gal expression in wild type T98 and U87 cells (control), cells with silenced LC3A (shLC3A cells), and following exposure to 4 Gy of radiation (on the 4th day).

  • 3
    • Download figure
    • Open in new tab
    • Download powerpoint
    3

    (A) Confocal images (100 x) and Western blot analysis of T98 and U87 glioblastoma cell lines stably transfected with shLC3A, shLC3B and shTFEB, showing successful suppression of protein expression (assessed in the supernatant fraction). (B) Growth delay dose/response curves, assessed on the 7 th day after irradiation, in the T98 and U87 cell lines without and with repression of the LC3A, LC3B, LC3A/B and TFEB protein expression, using siRNA. (C) Cell viability of the T98 and U87 cell lines after 24 h exposure to temozolomide (10 μΜ) or cisplatin (10 μΜ), in wild type and transfected cells with siLC3A, siLC3B or siTFEB (*P < 0.05, ** P < 0.01, *** P < 0.001).

  • 4
    • Download figure
    • Open in new tab
    • Download powerpoint
    4

    (A) Reduced expression of the LC3A-1 protein in the supernatant of T98 and U87 cell lines, following transfection with specific vs. random non-coding siRNAs. (B, C) Growth kinetics of the wild type and shLC3A transfected T98 (B) and U87 cell lines (C) following subcutaneous implantation in athymic mice. (D) A typical image of a U87 implanted tumor in an athymic mice showing different size of the wild type and shLC3A implanted tumors, 12 days after irradiation.

  • S3
    • Download figure
    • Open in new tab
    • Download powerpoint
    S3

    In vitro growth curves of T98 and U87 control cells and cells transfected with LC3A shRNA.

  • S4
    • Download figure
    • Open in new tab
    • Download powerpoint
    S4

    Growth curves of T98 glioblastoma cell lines following exposure to 4 Gy (A) and 8 Gy (B) and dose response curves (C). Growth curves of U87 glioblastoma cell lines following exposure to 4 Gy (d) and 8 Gy (e) and dose response curves (f).

PreviousNext
Back to top

In this issue

Cancer Biology and Medicine: 15 (3)
Cancer Biology & Medicine
Vol. 15, Issue 3
1 Aug 2018
  • Table of Contents
  • Index by author
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on Cancer Biology & Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Autophagic flux response and glioblastoma sensitivity to radiation
(Your Name) has sent you a message from Cancer Biology & Medicine
(Your Name) thought you would like to see the Cancer Biology & Medicine web site.
Citation Tools
Autophagic flux response and glioblastoma sensitivity to radiation
Achilleas G. Mitrakas, Dimitra Kalamida, Alexandra Giatromanolaki, Stamatia Pouliliou, Avgi Tsolou, Rafail Kyranas, Michael I. Koukourakis
Cancer Biology & Medicine Aug 2018, 15 (3) 260-276; DOI: 10.20892/j.issn.2095-3941.2017.0173

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Autophagic flux response and glioblastoma sensitivity to radiation
Achilleas G. Mitrakas, Dimitra Kalamida, Alexandra Giatromanolaki, Stamatia Pouliliou, Avgi Tsolou, Rafail Kyranas, Michael I. Koukourakis
Cancer Biology & Medicine Aug 2018, 15 (3) 260-276; DOI: 10.20892/j.issn.2095-3941.2017.0173
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • References
  • PDF

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • TNFSF15 facilitates the differentiation of CD11b+ myeloid cells into vascular pericytes in tumors
  • Efficacy and safety of gemcitabine plus S-1 vs. gemcitabine plus nab-paclitaxel in treatment-naïve advanced pancreatic ductal adenocarcinoma
  • Comparing effectiveness and safety of paclitaxel plus raltitrexed vs. paclitaxel alone in second-line palliative chemotherapy for metastatic gastric adenocarcinoma: A randomized phase II clinical trial
Show more Original Article

Similar Articles

Keywords

  • glioblastoma
  • autophagy
  • radiation
  • temozolomide
  • TFEB

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2023 Cancer Biology & Medicine

Powered by HighWire